US3097139A
(en)
*
|
1960-03-10 |
1963-07-09 |
Ici Ltd |
Hypocholesterolaemia compositions
|
BE630211A
(US20080293856A1-20081127-C00150.png)
*
|
1962-03-28 |
|
|
|
GB992152A
(en)
*
|
1962-07-11 |
1965-05-19 |
Prodotti Schering Soc It |
Aminoesters
|
US3332842A
(en)
*
|
1963-08-30 |
1967-07-25 |
Ciba Geigy Corp |
Ether acids and derivatives thereof
|
US3332957A
(en)
*
|
1964-09-02 |
1967-07-25 |
Ciba Geigy Corp |
Amino esters of substituted phenoxy acetic acids
|
SE337383B
(US20080293856A1-20081127-C00150.png)
*
|
1965-01-05 |
1971-08-09 |
Yoshitomi Pharmaceutical |
|
US3452081A
(en)
*
|
1965-05-27 |
1969-06-24 |
Merck & Co Inc |
Phenoxy substituted 2-alkenoic acids
|
US3538227A
(en)
*
|
1967-01-30 |
1970-11-03 |
Ciba Geigy Corp |
Tricyclic phenoxy-acid and ester hypocholesterolemic compositions
|
SE344742B
(US20080293856A1-20081127-C00150.png)
*
|
1968-09-25 |
1972-05-02 |
Ciba Geigy Ag |
|
US3716583A
(en)
*
|
1969-04-16 |
1973-02-13 |
Sumitomo Chemical Co |
Phenoxy carboxylic acid derivative
|
US4031134A
(en)
*
|
1969-04-16 |
1977-06-21 |
Sumitomo Chemical Company, Limited |
Phenoxy carboxylic acid derivative
|
US3692895A
(en)
*
|
1970-09-08 |
1972-09-19 |
Norman A Nelson |
Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
|
GB1348642A
(en)
*
|
1970-10-15 |
1974-03-20 |
Howard A N |
Hypocholesterolaemic compositions
|
JPS575214B2
(US20080293856A1-20081127-C00150.png)
*
|
1972-06-01 |
1982-01-29 |
|
|
US3952096A
(en)
*
|
1973-06-15 |
1976-04-20 |
Bristol-Myers Company |
Mixture of calcium carbonate and calcium-α-p-chlorophenoxyisobutyrate as an antihyperlipemic agent
|
DE2342118C2
(de)
*
|
1973-08-21 |
1982-09-23 |
Merck Patent Gmbh, 6100 Darmstadt |
Phenoxypropionsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
|
US4039683A
(en)
*
|
1973-08-21 |
1977-08-02 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Phenoxypropionic acid derivatives and pharmaceutical preparations containing same
|
US4182902A
(en)
*
|
1973-12-27 |
1980-01-08 |
Siegfried Aktiengesellschaft |
Novel cholesterol-lowering compounds
|
CH617417A5
(US20080293856A1-20081127-C00150.png)
*
|
1973-12-27 |
1980-05-30 |
Siegfried Ag |
|
NL7416412A
(nl)
*
|
1973-12-27 |
1975-07-01 |
Siegfried Ag |
Werkwijze ter bereiding van nieuwe cholesterol- gende verbindingen.
|
AT353776B
(de)
*
|
1973-12-27 |
1979-12-10 |
Siegfried Ag |
Verfahren zur herstellung von neuen alkan- saeuren, deren estern und salzen
|
US4012523A
(en)
*
|
1974-01-24 |
1977-03-15 |
The Dow Chemical Company |
Hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-(thio or sulfonyl) alkanoic acids and derivatives
|
US4067998A
(en)
*
|
1974-02-11 |
1978-01-10 |
The Dow Chemical Company |
2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivatives
|
DK115374A
(US20080293856A1-20081127-C00150.png)
|
1974-03-04 |
1975-11-03 |
Byk Gulden Lomberg Chem Fab |
|
US4243819A
(en)
*
|
1978-02-16 |
1981-01-06 |
Zoecon Corporation |
Substituted amino acids
|
US4250191A
(en)
*
|
1978-11-30 |
1981-02-10 |
Edwards K David |
Preventing renal failure
|
JPS58150563A
(ja)
*
|
1982-03-04 |
1983-09-07 |
Taisho Pharmaceut Co Ltd |
3−ベンゾイル−2−メルカプトプロピオン酸誘導体
|
US4704402A
(en)
*
|
1982-06-12 |
1987-11-03 |
University Of Pittsburgh |
Method of treating sickle cell anemia
|
US4482571A
(en)
*
|
1982-06-21 |
1984-11-13 |
University Of Pittsburgh |
Sickle cell anemia treatment and compound
|
IN160141B
(US20080293856A1-20081127-C00150.png)
*
|
1983-05-09 |
1987-06-27 |
Council Scient Ind Res |
|
EP0320501A3
(en)
*
|
1983-06-24 |
1989-12-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Phenoxy derivatives, their preparation, and pharmaceutical compositions containing them
|
ES533668A0
(es)
*
|
1983-06-24 |
1985-10-01 |
Yamanouchi Pharma Co Ltd |
Un compuesto fenoxi
|
DE3621861A1
(de)
*
|
1986-06-30 |
1988-01-14 |
Laszlo Dr Med Ilg |
Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen
|
US4859703A
(en)
*
|
1987-06-15 |
1989-08-22 |
Warner-Lambert Company |
Lipid regulating compositions
|
EP0515684A4
(en)
*
|
1990-02-14 |
1993-04-21 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibitor of denatured ldl formation
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US6262277B1
(en)
*
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6083497A
(en)
|
1997-11-05 |
2000-07-04 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
|
DE69905877T2
(de)
|
1998-06-02 |
2003-11-20 |
Arthromics Plc Wilmslow |
Substanzen, die mit dem thyroid-hormonrezeptor interagieren, zur behandlung fibrotischer erkrankungen
|
US6462091B1
(en)
|
1998-12-23 |
2002-10-08 |
G.D. Searle & Co. |
Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications
|
JP2002533409A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー.ディー.サール エルエルシー |
心臓血管に適用するためのコレステリルエステル転送タンパク質阻害剤および胆汁酸隔離剤の組み合わせ
|
EA009466B1
(ru)
*
|
1998-12-23 |
2007-12-28 |
Джи.Ди. Сирл Ллс |
Ингибитор белка, переносящего эфир холестерила
|
ATE242007T1
(de)
|
1998-12-23 |
2003-06-15 |
Searle Llc |
Kombinationen von cholesteryl ester transfer protein inhibitoren und nicotinsäure derivaten für kardiovaskuläre indikationen
|
PL348508A1
(en)
*
|
1998-12-23 |
2002-05-20 |
Searle Llc |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
|
KR20010102964A
(ko)
|
1998-12-23 |
2001-11-17 |
윌리암스 로저 에이 |
심장혈관 징후를 위한 회장 담즙산 수송 억제인자 및피브린산 유도체의 조합물
|
BR9916564A
(pt)
*
|
1998-12-23 |
2002-01-29 |
Searle Llc |
Combinações para indicações cardiovasculares
|
CA2356156A1
(en)
*
|
1998-12-23 |
2000-07-06 |
G.D. Searle Llc |
Combinations of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications
|
WO2001068096A2
(en)
*
|
2000-03-10 |
2001-09-20 |
Pharmacia Corporation |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
WO2001068637A2
(en)
|
2000-03-10 |
2001-09-20 |
Pharmacia Corporation |
Method for the preparation of tetrahydrobenzothiepines
|
US20040077625A1
(en)
*
|
2001-07-25 |
2004-04-22 |
Tremont Samuel J. |
Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake
|
MXPA04003524A
(es)
*
|
2001-11-02 |
2004-07-23 |
Searle Llc |
Compuestos de benzotiepina monofluorados y difluorados novedosos como inhibidores de transporte de acido biliar co-dependiente de sodio apical (asbt) y captacion de taurocolato.
|
MXPA04006255A
(es)
|
2002-01-17 |
2004-09-27 |
Pharmacia Corp |
Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
|
ITRM20020629A1
(it)
*
|
2002-12-19 |
2004-06-20 |
Sigma Tau Ind Farmaceuti |
Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
|
WO2004108126A1
(en)
*
|
2003-06-06 |
2004-12-16 |
Snowden Pharmaceuticals, Llc |
Fibric acid derivatives for the treatment of irritable bowel syndrome
|
US7390504B2
(en)
*
|
2003-11-07 |
2008-06-24 |
Jj Pharma, Inc. |
HDL-boosting combination therapy complexes
|
US20070190079A1
(en)
*
|
2004-10-29 |
2007-08-16 |
Kalypsys, Inc. |
Methods for the selective modulation of ppar
|
FR2880887B1
(fr)
*
|
2005-01-14 |
2009-01-30 |
Merck Sante Soc Par Actions Si |
Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
|
AR063275A1
(es)
*
|
2006-10-12 |
2009-01-14 |
Epix Delaware Inc |
Compuestos de carboxamida, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la activacion de ccr2.
|
AR065670A1
(es)
|
2007-03-09 |
2009-06-24 |
Indigene Pharmaceuticals Inc |
Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas
|
WO2008157537A2
(en)
*
|
2007-06-19 |
2008-12-24 |
Ironwood Pharmaceuticals, Inc |
Compositions and methods of use for treating or preventing lipid related disorders
|
WO2009076404A1
(en)
*
|
2007-12-10 |
2009-06-18 |
Epix Delaware, Inc. |
Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
|
RU2010128543A
(ru)
|
2007-12-11 |
2012-01-20 |
Сайтопатфайндер, Инк. (Jp) |
Карбоксамидные соединения и их применение в качестве агонистов хемокиновых рецепторов
|
UA106886C2
(uk)
|
2009-08-03 |
2014-10-27 |
Ацьєнде Кіміке Ріуніте Анджеліні Франческо А.Чі.Р.А.Ф. С.П.А. |
Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та проміжні сполуки магнію
|
PE20180027A1
(es)
|
2015-02-06 |
2018-01-09 |
Intercept Pharmaceuticals Inc |
Composiciones farmaceuticas para terapia combinada
|
KR101956805B1
(ko)
*
|
2019-02-21 |
2019-03-11 |
한국식품연구원 |
부테인 또는 이소유제놀을 포함하는 pcsk9 유전자의 발현 감소 또는 저밀도 지단백 수용체 증가용 조성물
|